The present invention is directed toward a composition comprising a compound isolated from Dysidea species sponges that is capable of inhibiting serine proteases of the coagulation cascade. In particular, this composition inhibits the TF/VIIa complex of the coagulation cascade. The invention is also directed toward methods employing this composition as a part of anticoagulant therapy.

 
Web www.patentalert.com

< Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

< DNA encoding bovine immunoglobulin a inducing protein and uses therefor

> Hepatitis C virus constructs characterized by high efficiency replication

> Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
~ 00206